TIME |
HALL A |
HALL B |
13:30 – 13:45 |
Opening Ceremony Speakers: Güner Hayri Özsan (Dokuz Eylül University, Turkey), Muhlis Cem Ar (İstanbul University -Cerrahpaşa, Turkey), Şule Ünal Cangül (Hacettepe University, Turkey), Meltem Kurt Yüksel (Ankara University, Turkey), Reyhan Küçükkaya (Turkey), Neslihan Andıç (Eskişehir Osmangazi University, Turkey), Leylagül Kaynar (Erciyes University, Turkey) |
13:45 – 14:00 |
Break |
14:00-15:30 |
MULTIPLE MYELOMA |
PEDIATRIC LEUKEMIAS-I |
Scientific Chair: Ömür Gökmen Sevindik (Medipol University, Turkey), Pieter Sonneveld (Erasmus MC, Netherlands) Antibodies Upfront or at Relapse?: Pieter Sonneveld (Erasmus MC, Netherlands) What is the Best Treatment Sequence for RRMM?: Thierry Facon (Lille University Hospital, France) Is MRD the New Outcome in Clinical Practice?: Francesca Gay (City of Health and Science University Hospital of Turin, Italy) |
Scientific Chair: Hale Ören (Dokuz Eylül University, Turkey), Michael Dworzak (St. Anna Children’s Hospital, Austria)
Advancements of the I-BFM FLOW Network: Innovative Solutions for Diagnosis and MRD Assessment in Acute Leukemias: Michael Dworzak (St. Anna Children’s Hospital, Austria)
FLOW-MRD in the Era of BITE & CART Therapies: Alexander Popov (Federal Research and Clinical Centre, Russia)
Towards shaping a high-quality network of FLOW-MRD labs in Turkey: Günnur Deniz (Istanbul University, Turkey)
|
15:30 – 16:00 |
Break |
16:00 – 16:45 |
SATELLITE SYMPOSIUM
New Dimension in Efficacy: Darzalex in RRMM
Scientific Chair: Meral Beksaç (Ankara University, Turkey) Speakers: Erdal Kurtoğlu (Antalya Training and Research Hospital, Turkey), Ömür Gökmen Sevindik (Medipol University, Turkey)
|
|
16:45 – 17:15 |
Break |
17:15 – 18:45 |
CHRONIC MYELOID LEUKEMIA |
PEDIATRIC LEUKEMIAS-II |
Scientific Chair: Ahmet Emre Eşkazan (İstanbul University -Cerrahpaşa, Turkey), Susanne Saussele (University Hospital Mannheim, Germany)
Modern CML Treatment According to the New ELN Recommendations: Mario Tiribelli (University of Udine, Italy)
Treatment Free Remission. A Goal for All CML Patients?: Susanne Saussele (University Hospital Mannheim, Germany)
New Options for Patients After 1st Line: Ahmet Emre Eşkazan (İstanbul University -Cerrahpaşa, Turkey)
|
Scientific Chair: Volkan Hazar (Medstar Hospital, Turkey), Fatih Okcu (Texas Children’s Hospital, USA)
Epidemiology of Late Effects in Children with Acute Lymphoblastic Leukemia: Fatih Okcu (Texas Children’s Hospital, USA)
Obesity and Metabolic Syndrome in Childhood Acute Lymphoblastic Leukemia Survivors: Kala Kamdar (Texas Children’s Hospital, USA)
Early Aging, Chronic Conditions and Biological Indicators of Aging in Childhood Acute Lymphoblastic Leukemia Survivors: Monica Gramatges (Texas Children’s Hospital, USA)
|
18:45 – 19:15 |
Break |
19:15 – 20:45 |
INDOLENT LYMPHOMAS |
|
Scientific Chair: Meltem Olga Akay ( Koç University , Turkey), Eva Kimby (Karolinska Institute, Sweden) Follicular Lymphoma with Focus on Therapy: Eva Kimby (Karolinska Institute, Sweden) Cellular Therapies for Follicular Lymphoma: Koen Van Besien (Presbyterian Hospital, USA) Management of Marginal Zone Lymphoma: Catherine Thieblemont (Hôpital Saint-Louis, France) |
|
20:45 – 21:00 |
Break |
21:00-21:45 |
SATELLITE SYMPOSIUM
Carfilzomib Treatment in Relapsed/Refractory Multiple Myeloma
Scientific Chair: Tülin Tuğlular (Marmara University, Turkey) Speaker: Joseph Mikhael (Translational Genomic Research Institute, USA)
|
|
21:45 – 22:00 |
Break |
22:00 – 23:00 |
ORAL PRESENTATIONS |